80 likes | 369 Views
To Get More Info. Visit: http://www.analyzefuture.com/cervical-dysplasia-pipeline-review-h2-2014-market Cervical Dysplasia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cervical Dysplasia - Pipeline Review, H2 2014’, provides an overview of the Cervical Dysplasia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cervical Dysplasia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
E N D
Cervical Dysplasia - Pipeline Review, H2 2014 No. Pages : 66 Published on : Dec-2014
Report Description Cervical Dysplasia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cervical Dysplasia - Pipeline Review, H2 2014’, provides an overview of the Cervical Dysplasia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cervical Dysplasia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cervical Dysplasia and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. To Get More Info. Visit : http://www.analyzefuture.com/cervical-dysplasia-pipeline-review-h2-2014-market
Report Description Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. To Enquire Visit @http://www.analyzefuture.com/cervical-dysplasia-pipeline-review-h2-2014-market/report-enquiry The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Cervical Dysplasia - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
Table of Content Table Of ContentsTable of ContentsTable of Contents 2List of Tables 4List of Figures 4Introduction 5Global Markets Direct Report Coverage 5Cervical Dysplasia Overview 6Therapeutics Development 7Pipeline Products for Cervical Dysplasia - Overview 7Pipeline Products for Cervical Dysplasia - Comparative Analysis 8Cervical Dysplasia - Therapeutics under Development by Companies 9Cervical Dysplasia - Therapeutics under Investigation by Universities/Institutes 10Cervical Dysplasia - Pipeline Products Glance 11Clinical Stage Products 11Early Stage Products 12
Table of Content Cervical Dysplasia - Products under Development by Companies 13Cervical Dysplasia - Products under Investigation by Universities/Institutes 14Cervical Dysplasia - Companies Involved in Therapeutics Development 15CEL-SCI Corporation 15Helix Bio Pharma Corp. 16Inovio Pharmaceuticals, Inc. 17PDS Biotechnology Corporation 18VLPbio 19Cervical Dysplasia - Therapeutics Assessment 20Assessment by Monotherapy Products 20Assessment by Target 21Assessment by Mechanism of Action 23Assessment by Route of Administration 25Assessment by Molecule Type 27Drug Profiles 29CerviVax - Drug Profile 29Product Description 29Mechanism of Action 29R&D Progress 29
Table of Content CIGB-228 - Drug Profile 30Product Description 30Mechanism of Action 30R&D Progress 30interferon alpha-2b (recombinant) - Drug Profile 31Product Description 31Mechanism of Action 31R&D Progress 31Leukocyte Interleukin - Drug Profile 33Product Description 33Mechanism of Action 33R&D Progress 33PDS-0101 - Drug Profile 36Product Description 36Mechanism of Action 36R&D Progress 36Vaccine for Cervical Intraepithelial Neoplasia - Drug Profile 37
Table of Content Product Description 37Mechanism of Action 37R&D Progress 37VGX-3100 - Drug Profile 39Product Description 39Mechanism of Action 39R&D Progress 39Cervical Dysplasia - Recent Pipeline Updates 40Cervical Dysplasia - Dormant Projects 53Cervical Dysplasia - Discontinued Products 54Cervical Dysplasia - Product Development Milestones 55 To Get Complete TOC Visit at: http://www.analyzefuture.com/cervical-dysplasia-pipeline-review-h2-2014-market/table-of-contents Upcoming Reports : http://www.analyzefuture.com/nerve-repair-regeneration-market
FOR MORE DETAILS Visit us at : http://www.analyzefuture.com/ Stay With Us: 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States. TELEPHONE: +1 (855) 711-1555 EMAIL: sales@analyzefuture.com